英搏爾(300681.SZ):發行可轉債申請獲深交所受理
格隆匯6月7日丨英搏爾(300681.SZ)公佈,公司於2023年6月6日收到深圳證券交易所(“深交所”)出具的《關於受理珠海英搏爾電氣股份有限公司向不特定對象發行可轉換公司債券申請文件的通知》(深證上審〔2023〕405號)。深交所對公司報送的向不特定對象發行可轉換公司債券的申請文件進行了核對,認為申請文件齊備,決定予以受理。
公司本次向不特定對象發行可轉換公司債券事項尚需通過深交所審核,並獲得中國證券監督管理委員會作出同意註冊的決定後方可實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.